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The epidemiological landscape 
of anemia in women 
of reproductive age in sub‑Saharan 
Africa
Esteban Correa‑Agudelo1,2, Hae‑Young Kim3,4,5, Godfrey N. Musuka6, 
Zindoga Mukandavire7,8, F. DeWolfe Miller9, Frank Tanser3,10,11,12 & Diego F. Cuadros1,2*
The role of geographical disparities of health‑related risk factors with anemia are poorly documented 
for women of reproductive age in sub‑Saharan Africa (SSA). We aimed to determine the contribution 
of potential factors and to identify areas at higher risk of anemia for women in reproductive age in 
SSA. Our study population comprised 27 nationally representative samples of women of reproductive 
age (15–49) who were enrolled in the Demographic and Health Surveys and conducted between 
2010 and 2019 in SSA. Overall, we found a positive association between being anemic and the 
ecological exposure to malaria incidence [adjusted odds ratio (AOR) = 1.02, 95% confidence interval 
(CI) 1.02–1.02], and HIV prevalence (AOR = 1.01, CI 1.01–1.02). Women currently pregnant or under 
deworming medication for the last birth had 31% (AOR = 1.31, CI 1.24–1.39) and 5% (AOR = 1.05, CI 
1.01–1.10) higher odds of having anemia, respectively. Similarly, women age 25–34 years old with 
low education, low income and living in urban settings had higher odds of having anemia. In addition, 
underweight women had 23% higher odds of suffering anemia (AOR = 1.23, CI 1.15–1.31). Females 
with low levels of education and wealth index were consistently associated with anemia across SSA.  
Spatial distribution shows increased risk of anemia in Central and Western Africa. Knowledge about 
the contribution of known major drivers and the spatial distribution of anemia risk can mitigate 
operational constraints and help to design geographically targeted intervention programs in SSA.
Anemia is a major worldwide blood disorder related to an abnormally low concentration of hemoglobin protein 
in red blood cells (RBC). There are several conditions that alter RBC morphology and hemoglobin concentra-
tion including iron-deficiency, genetic mutations (e.g. sickle cell), abrupt blood loss, or infectious  diseases1. 
According to the Global Burden of Disease (GBD), anemia affects 27% of the world’s population (1.93 billion), 
causing 8.8% of the total disability for all conditions in 2010. Sub-Saharan Africa (SSA) is a region especially 
vulnerable to anemia, with an estimated 190 million cases occurring in SSA  countries2. Preschool children are 
at the highest risk, contributing to 43% of total anemia cases, followed by women of reproductive age (29% 
anemic in non-pregnant and 38% in pregnant women). Without proper treatment, anemia can cause numer-
ous health outcomes in adults including fatigue, low work productivity, and heart failure. In children, anemia 
can affect cognitive and motor development, and directly contribute to child and maternal  mortality3. In SSA, 
anemia frequently co-occur with other health conditions and comorbidities, including infectious diseases such 
as malaria, schistosomiasis, and  HIV4–7.
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Previous studies have shown geographic and demographic disparity of  anemia2,8. Some studies have assessed 
the geographical variation of anemia and the contribution of malnutrition, malaria, and helminth infections in 
preschool children in  SSA9, and among male populations in  India10. Another study reported geographical associa-
tion of anemia with malaria deaths in  SSA11. Although these studies showed evidence of the spatial variation of 
anemia, they were geographically and epidemiologically limited, with scarce information of vulnerable popula-
tions like women, or related comorbidities in SSA. In terms of control strategies, large efforts in Africa have been 
focused on nutrition-related interventions including iron supplementation and food fortification  programs12. 
Other strategies from the United Nations Children’s Fund (UNICEF) and World Health Organization (WHO) 
have focused on controlling infectious diseases through deworming, malaria prevention (insecticide-treated net 
[ITN]) and water and sanitation  agenda13,14. However, the high burden of anemia in SSA and the presence other 
health-related conditions require additional efforts from governments to identify, track, and tailor interventions 
on vulnerable populations and geographic areas where the burden of anemia is concentrated. Therefore, this 
study aims to: (a) assess the contribution of potential risks factors and comorbidities associated with anemia 
for women in reproductive age; and (b) identify the locations where the burden of the disease is concentrated 
in SSA. We hypothesized that women in reproductive age living in areas with high prevalence of comorbidities 
and poor sanitation conditions are adversely affected by anemia in SSA.
Methods
Study area and data sources. Our study used observational data from the population-based Demo-
graphic Health Survey (DHS) conducted between 2010 and 2019 in 27 countries in SSA. Data for anemia status 
and associated socioeconomic and demographic factors for 384,291 women of reproductive age (15–49 years) 
were obtained from the most recent standard and continuous DHS, including: Burundi (BDI), Benin (BEN), 
Burkina Faso (BFA), Ivory Coast (CIV), Cameroon (CMR), Democratic Republic of Congo (COD), Congo 
(COG), Ethiopia (ETH), Gabon (GAB), Ghana (GHA), Guinea (GIN), The Gambia (GMB), Lesotho (LSO), 
Mali (MLI), Mozambique (MOZ), Malawi (MWI), Namibia (NAM), Niger (NER), Nigeria (NGA), Rwanda 
(RWA), Senegal (SEN), Sierra Leone (SLE), Togo (TGO), Tanzania (TZA), Uganda (UGA), South Africa (ZAF) 
and Zimbabwe (ZWE). Data on two comorbidities, malaria and HIV, were obtained from the Malaria Atlas Pro-
ject (MAP) and the Institute for Health Metrics and Evaluations (IHME)15,16. Inequality in accessibility to health 
resources was quantified using predicted travel time in hours to the nearest city from  MAP17. The unit of analysis 
(Admin1 territory) was derived from the spatial data repository for DHS (http:// spati aldata. dhspr ogram. com/) 
to match each country’s sampling design and site locations.
Study variables. The primary outcome of interest was the anemia status. Women were grouped into two 
categories: “non-anemic”, and “anemic”. DHS determines anemia status by measuring hemoglobin concentra-
tion in blood samples adjusted by altitude in grams per deciliter (g/dl) as defined in the WHO’s  guideline18. For 
pregnant women, hemoglobin levels below 10.9 g/dl were considered anemic. For non-pregnant women, hemo-
globin levels below 11.9 g/dl were considered anemic.
Due to the strong co-occurrence of anemia with other health conditions in SSA, we extracted and averaged 
the 2015 malaria incidence (Plasmodium falciparum incidence rate [PfIR]), and 2015 HIV prevalence estimates 
at the minimum unit of analysis available in DHS (Admin1). For maternity history, we included: pregnancy 
status, iron supplementation, and deworming during  pregnancy19,20. Sociodemographic covariates included 
age, type of residence, education, source of drinking water, wealth index, body mass index (BMI), and smoking 
cigarettes. Covariates were classified using appropriate levels: pregnancy status (yes or no/unsure), iron sup-
plementation during pregnancy (yes or no), and deworming during pregnancy (yes or no), age groups (15–24, 
25–34, 35–44, 45 +), type of residence (urban or rural), education (no education, primary/secondary or higher), 
source of drinking water (improved or unimproved), wealth index combined (poorest, poorer, middle, richer or 
richest), BMI (underweight or normal/obese), and smoking cigarettes (yes or no). Inequality in accessibility to 
health resources was assessed using the spatial average procedure on the travel time surface for each Admin1. 
This study follows the guidelines of the Strengthening the Reporting of Observational Studies in Epidemiology 
(STROBE)21. Additional information about each country’s DHS studies and variables, and STROBE checklist is 
included in Supplemental Material (See Appendix A and B).
Statistical analysis. Population surveys from each country were combined into a full dataset, preserv-
ing sampling procedure. All covariates were selected according to an evidence synthesis process of relevant 
 references7,10,19,22–26. To evaluate multicollinearity, a Variance Inflated Factor (VIF) was estimated including 
all covariates. All variables with a VIF lower than five (VIF < 5.0) were included in the final adjusted model 
(See Table S3). Finally, unadjusted and adjusted logistic regression models were fitted to assess the association 
between anemia status and the selected covariates using the full dataset. All models were weighted and adjusted 
accordingly to the sample design as recommended by  DHS27. Note that only individuals who completed the 
survey with a valid anemia test were included in the analysis.
Spatial risk and disease mapping. For the geographic mapping, a Bayesian spatial Poisson model was 
used to estimate relative risks of  anemia28. Benefits from the model-based approach are twofold: first, they allow 
to introduce a reference population to obtain reliable risk estimates of a disease based on standardized incidence 
ratios (ratio of the observed to the expected disease counts [SIRs]). Second, disease models offer a smoothing 
mechanism to improve local risk estimates while avoiding extreme values of areas with small populations when 
incorporating mixed effects and spatial dependence (relative risk [RR]). For counts, observed anemia cases were 
aggregated at the minimum unit of analysis available (Admin1) following the DHS sampling  procedure27. For 
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the expected cases, an indirect age-standardization was included using the United Nation Adjusted Gridded 
Population surface for 2015 (100 m × 100 m grid resolution)29. This population surface was combined with the 
Admin1 boundaries and the 2015 World Bank estimates for population and age distribution of women aged 
15–49 living in those areas to standardize the outcome across all  locations30. Admin1 areas with a 95% Bayesian 
credible interval (CrI) that falls within the mean (1) indicates the same RR as expected from the reference popu-
lation. Conversely, CrI > 1 or CrI < 1 were locations with low and high risk respectively. Detailed information is 
included in Supplemental Material (See Appendix B and C).
All maps generated in this study were created using R programming environment, version 3.6.3 (https:// 
cran.r- proje ct. org/ bin/ windo ws/ base/ old/3. 6.3/) including packages INLA31,32, SpatialEpi33, ggplot2 and raster.
Ethics approval. Procedures and questionnaires for standard Demographic and Health Surveys have been 
reviewed and approved by the Inner-City Fund (ICF) International Institutional Review Board (IRB). The ICF 
International IRB ensures that the survey complies with the US Department of Health and Human Services 
regulations for the protection of human subjects, while the host country IRB ensures that the survey complies 
with laws and norms of the nation (http:// dhspr ogram. com/ What- We- Do/ Prote cting- the- Priva cy- of- DHS- Sur-
vey- Respo ndents. cfm% 23sth ash. Ot3N7 n5m. dpuf).
Informed consent. All DHS surveys comprised in this study included informed consent statements agreed 
to by the participants (https:// dhspr ogram. com/ metho dology/ Prote cting- the- Priva cy- of- DHS- Survey- Respo 
ndents. cfm).
Results
Sociodemographic and socio‑environmental variables. Of the 384,291 women aged 15–49, 198,841 
individuals within 14,327 survey sites in 289 Admin1 areas met the inclusion criteria (had valid anemia test 
results and completed the survey) (Fig. 1). Table 1 presents descriptive statistics of population included in the 
study. The overall proportion of women with anemia was 43.3% (86,117) across the 27 countries studied. The 
highest prevalence was found in West (mean [µ] = 51.3, standard error [SE]:0.0), followed by Central (µ = 47.5, 
SE:0.01), Eastern (µ = 35.4, SE:0.0) and Southern (µ = 35.1, SE:0.01) Africa regions, respectively. Higher PfIR was 
found in anemic females compared to non-anemic females (24.3% vs 20.0%; p < 0.001). Likewise, HIV preva-
lence was lower in the anemic group (4.2% vs 4.7%; p < 0.01). For maternity covariates, the proportion of women 
in pregnancy, and the proportion of women who had received drugs for intestinal parasites were greater in 
the anemic group, 10.8% vs 7.8% (p < 0.001), and 23.2% vs 21.1% (p < 0.001). Low levels of education, use of 
unimproved source of water, and low wealth index were more common in anemic individuals, 36.9% vs 28.9% 
(p < 0.001), 27.3% vs 25.2% (p < 0.001), and 19.1% vs 16.5% (p < 0.001), respectively. Being underweight was 
more common in anemic compared to non-anemic individuals (10.7% vs 9.6%; p < 0.001). Finally, mean travel 
time to nearest city within Admin1 regions was lower in the anemic group  (2.39 h vs 2.44 h; p = 0.027).
Multivariate analyses of risk factors for anemia. Table 2 summarizes the results from the adjusted 
model for the association between anemia status and the covariates in all countries. For comorbidities, the eco-
Figure 1.  Flowchart of data identification, extraction and curation. PSU = Primary sampling unit, 
PfIR = Plasmodium falciparum incidence rate.
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Table 1.  Population characteristics by anemic status and Admin1-level covariates.
Anemia Status
No anemia Anemia
n (%) n (%)
Sample 112,724 (56.7) 86,117 (43.3)
Comorbidities µ (SD) µ (SD) p-value
PfIR (Admin1) 20.0 (0.09) 24.3 (0.11)  < 0.001
HIV (Admin1) 4.7 (0.03) 4.2 (0.03)  < 0.001
Currently pregnant  < 0.001
No or unsure 103,943 (92.2) 76,801 (89.2)
Yes 8,808 (7.80) 9,316 (10.8)
Age (years) 28.54 (0.03) 28.53 (0.04) 0.874
Age-group
15–24 44,248 (39.3) 34,171 (39.7)  < 0.001
25–34 36,831 (32.7) 27,241 (31.6)
35–44 23,371 (20.7) 18,438 (21.4)
45 + 8,275 (7.3) 6267 (7.3)
Type of place
Urban 42,169 (37.4) 32,788 (38.1) 0.087
Rural 70,555 (62.6) 53,329 (61.9)
Education
No education 32,562 (28.9) 31,781 (36.9)  < 0.001
Primary 38,178 (33.9) 25,695 (29.8)
Secundary 36,557 (32.4) 25,552 (29.7)
Higher 5,425 (4.8) 3,084 (3.6)
Type of water
Improved source 81,609 (72.4) 60,499 (70.3)  < 0.001
Unimproved source 28,364 (25.2) 23,537 (27.3)
Missing data 2,751 (2.4) 2,081 (2.4)
Wealth Index
Poorest 18,553 (16.5) 16,464 (19.1)  < 0.001
Poorer 20,439 (18.1) 16,695 (19.4)
Middle 21,397 (19.0) 17,100 (19.9)
Richer 24,031 (21.3) 17,515 (20.3)
Richest 28,305 (25.1) 18,342 (21.3)
BMI
Obese 28,210 (25.0) 17,917 (20.8)  < 0.001
Normal 69,825 (61.9) 54,594 (63.4)
Underweight 10,805 (9.6) 9,192 (10.7)
Missing data 3,884 (3.4) 4,414 (5.1)
Smoking cigarettes
No 106,974 (94.9) 82,278 (95.5) 0.272
Yes 1,010 (0.9) 725 (0.8)
Missing data 4,741 (4.2) 3,114 (3.6)
Iron supplementation during pregnancy
No 11,626 (10.3) 8,967 (10.4) 0.363
Yes 38,168 (33.9) 28,821 (33.5)
Missing data 62,931 (55.8) 48,329 (56.1)
Deworming during pregnancy
No 32,646 (29.0) 25,696 (29.8)  < 0.001
Yes 23,768 (21.1) 19,974 (23.2)
Missing data 56,311 (50.0) 40,446 (47.0)
µ (SD) µ (SD) 0.027
Accessibility to main cities (hour) 2.44 (0.02) 2.39 (0.02)
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logical exposure to a higher incidence of malaria or HIV prevalence were positively associated with having 
anemia. These translate to increases in the odds of having anemia for each one-unit increase in the regional PfIR 
(adjusted odds ratio [AOR] = 1.02, 95% confidence interval [CI] 1.02–1.02) and HIV prevalence (AOR = 1.01, 
CI 1.01–1.02), respectively. For maternity covariates, pregnancy and deworming increased the odds of having 
anemia by 31% (AOR = 1.31, CI 1.24–1.39) and 5% (AOR = 1.05, CI 1.01–1.10), respectively. Females between 
25 and 34 years old and living in rural settings were 10% (AOR = 0.90, CI 0.86–0.94) and 20% (AOR = 0.80, CI 
0.75–0.85) less likely to have anemia. Anemia more likely occurred in women with low education and low wealth 
index settings. Females with an unimproved source of water had 6% higher odds of having anemia (AOR = 1.06, 
CI 1.01–1.11). Similarly, individuals with underweight were 23% (AOR = 1.23, CI 1.15–1.31) more likely to have 
anemia. Smoking cigarettes and iron supplementation during pregnancy were not associated with being anemic. 
Lastly, women living in regions with longer distances to main cities had the decreased odds of having anemia by 
1% per hour of travel time.
Spatial risk and disease mapping. Figure 2 and Table S6 illustrate the RR of anemia for women in repro-
ductive age for all countries in SSA. Overall, we found that 76 out of the 289 Admin1 locations had significantly 
Table 2.  Predictors for anemia in women of reproductive age in SSA. Notes: Boldfaced numbers indicate 
statistical association <0.05. Abbreviations: AOR, adjusted odds ratio; CI, confidence interval.
AOR (95% CI)
Comorbidities
PfIR 1.02 (1.02, 1.02)
HIV prevalence 1.01 (1.01, 1.02)
Currently Pregnant
No or unsure Ref
Yes 1.31 (1.24, 1.39)
Iron supplementation during pregnancy
No Ref
Yes 0.97 (0.92, 1.01)
Deworming during pregnancy
No Ref
Yes 1.05 (1.01, 1.10)
Age-group
15–24 Ref
25–34 0.90 (0.86, 0.94)
35–44 0.97 (0.92, 1.02)
45 + 0.91 (0.81, 1.03)
Type of place
Urban Ref
Rural 0.80 (0.75, 0.85)
Education
Higher Ref
Primary/Secondary 1.15 (1.02, 1.30)
No education 1.65 (1.46, 1.87)
Improved source of water Ref
Unimproved source of water 1.06 (1.01, 1.11)
Wealth Index
Richest Ref
Richer 1.11 (1.04, 1.19)
Middle 1.21 (1.13, 1.31)
Poorer 1.23 (1.14, 1.34)
Poorest 1.34 (1.24, 1.45)
BMI
Normal/Obese Ref
Underweight 1.23 (1.15, 1.31)
Smoking cigarettes
No Ref
Yes 1.08 (0.87, 1.34)
Accessibility to main cities (hour) 0.99 (0.98, 0.99)
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Figure 2.  Estimated anemia risk among women in Sub-Saharan Africa (range is 0.22–7.05). Maps were 
generated using R programming environment, version 3.6.3 (https:// cran.r- proje ct. org/ bin/ windo ws/ base/ old/3. 
6.3/).
Table 3.  Top-five highest risk areas for anemia in SSA.
Region
Anemia 
Prevalence (%) Pregnancy (%)










source of water 
(%)
Pointe-noire, COG 0.60 0.09 0.25 0.00 0.01 0.00 0.01 0.03
Libreville & Port-
gentil, GAB 0.62 0.10 0.20 0.01 0.03 0.00 0.06 0.02
Banjul, GMB 0.52 0.07 0.37 0.00 0.00 0.00 0.22 0.01
Bas-Congo, COD 0.55 0.11 0.50 0.06 0.00 0.71 2.69 0.36
Bandundu, COD 0.38 0.13 0.49 0.22 0.00 0.79 7.96 0.69
Women in 




RR CrI: [2.5%, 
97.5%]
0.12 0.20 3.53 7.05 [6.59, 7.53]
0.06 0..24 3.88 4.35 [4.15, 4.55]
0.11 0.02 1.62 3.93 [2.89, 5.13]
0.22 0.26 0.47 1.98 [1.74, 2.23]
0.24 0.21 0.43 1.86 [1.71, 2.01]
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higher risk of anemia (CrI > 1). Eastern and Western Africa accounted for 32 and 25 high-risk locations, whereas 
Central and Southern Africa had 14 and five, respectively. All 27 countries had at least one or more Admin1 
locations which had a higher risk than average. Four countries had half or more of their regions at high-risk: 
COD (55%), GMB (62%), NGA (50%), and MOZ (55%). Table 3 reports the top-five Admin1 by RR. Pointe 
Noire (RR = 7.05, CrI 6.59, 7.53) in COG, Libreville & Port-Gentil (RR = 4.35, CrI 4.15, 4.55) in GAB, Banjul 
(RR = 3.93, CrI 2.89, 5.13) in GMB, Bas-Congo (RR = 1.98, CrI 1.74, 2.23) and Bandundu (RR = 1.86, CrI 1.71, 
2.01) in COD. Additional details can be found in the supplemental material (See Appendix B and C).
Discussion
This study provides a comprehensive characterization of health and sociodemographic determinants of anemia, 
and the identification of geographic areas where the burden of anemia in women of reproductive age is con-
centrated in SSA. We found that high prevalence of co-occurrent health conditions like malaria and HIV might 
exacerbate the burden of anemia in women. Women currently pregnant or under deworming medication for 
the last birth were more likely to have anemia. Similarly, anemia was more likely in women aged 25–34 years 
old, with low education, low income and living in urban settings. In addition, underweight women were 23% 
more likely to suffer anemia. Finally, our spatial analysis highlights high-risk areas that are worth noting for 
geographically targeted interventions.
Compared to the WHO latest anemia prevalence estimate in SSA (38%, CI 32.7, 45.4), our anemia estimated 
prevalence of 43% is slightly higher but within the WHO’s confidence intervals for Africa  continent34. Although 
our regional estimates did not completely match other previous  estimates2,8, our estimates lie within the confi-
dence intervals of their estimates and present similar trends with very high prevalence in Central and Western 
Africa (> 47%). Likewise, our estimates are higher for non-pregnant (42% vs 29%) and pregnant women (51% 
vs 38%), compared to Stevens et al8. Since DHS surveys are collected in different years, each country might have 
different prevalences than the estimates used in WHO and other studies at the moment of the study.
Our study also highlights the co-occurrence of anemia with other highly prevalent health conditions in SSA, 
such as malaria and HIV. We found women living in areas with a regional PfIR mean of 21.4% (range 0.5–62.3) 
had twice the odds of having anemia. Although children aged under-five face the highest risk of malaria, low birth 
weight and malaria-related mortality can affect women, especially pregnant  women4. Despite recent progress of 
Central and Eastern Africa in malaria  prevention35, considerable risk persists in highly prevalent anemia areas 
(Central and Western Africa). Therefore, combined interventions including ITNs, antimalarial treatments, and 
education can foster the results not only in malaria but subsequently in anemia, especially in the high burden 
areas of anemia in Central and Western Africa identified in this study. Similarly, we found a significant link 
between HIV and anemia. Africa exhibits the highest burden of HIV (~ 25 million people living with HIV) 
particularly affecting specific high-risk groups (e.g., young females)36. In addition, the prevalence of anemia in 
people living with HIV might reach 80–90% under certain  conditions7. During a lifetime, about 30% of HIV 
patients suffer anemia frequently due to blood loss (e.g., sarcoma), decreased or ineffective RBC production and 
RBC destruction. The health outcome for patients with both conditions varies from decreased survival rates to 
faster disease progression in HIV  patients37. Clinical efforts including special regimens (differential diagnostic, 
diet, treatment and dosage) and extra monitoring for patience adherence can help to diminish anemia in HIV-
positive populations.
Education attainment was associated with anemia in women, showing higher odds for females with low levels 
of education, which could be also linked to malnutrition and unimproved sources of drinking water. These fac-
tors could collectively be pressing manifestations of the link between poverty and anemia in  SSA8,14,38,39. Several 
implications might be derived from this poverty-anemia relationship. First, low education and income levels 
might influence women’s awareness of health issues related to unhealthy dietary habits and access to good nutri-
tional food sources. Second, early-life underweight has later chronic disease outcomes and other disabilities in 
adults. In pregnancy, maternal undernutrition may result in a three-fold increased risk of low birth weight or 
cardiovascular diseases in  adulthood40–42. Lastly, lack of access to an improved source of drinking water increases 
not only the odds of anemia but also numerous water-borne and neglected tropical diseases, including cholera, 
schistosomiasis, among other  diseases9. Because poverty-related anemia possesses these critical characteristics, 
it would be essential for authorities to prioritize hybrid interventions based on the Sustainable Development 
Goals (SDGs) including scaling-up iron and fortified food interventions  (2nd SDG, Zero hunger), health educa-
tion, drug-based deworming particularly for pregnant women and water and sanitation  (6th SDG, Clean water 
and sanitation) for greater impact on population at risk of anemia.
According to our spatial analysis, 76 subnational regions (Admin1; 26% of the total number of subnational 
regions included in the study) had a significantly higher risk of anemia than the SSA reference. Central and 
Eastern Africa each accounted for about 31% of high-risk locations. Likewise, Western and Southern Africa had 
about 23% and 16% of high-risk locations, respectively. At national level, all countries had at least one high-risk 
subnational location, and four countries had 50% or more of their regions at risk: COD (6 out of 11), GMB (5 
out of 8), MOZ (6 out of 11), and NGA (3 out of 6). At Admin1-level, noteworthy is that COD (Bas-Congo, 
and Bandundu) and GMB (Banjul) are also present with three of the top-five highest risk locations, led by COG 
(Pointe Noire) and GAB (Libreville & Port-gentil). Reasons for the increased spatial risk of anemia in these 
territories could be manifold: first, the increased urbanization trend of  Africa43 might explain the protective 
effect of rural and accessibility covariates, and why several high-risk locations are mainly urban, including the 
top-three regions, Pointe Noire (COG), Libreville & Port-gentil (GAB), and Banjul (GMB). Second, proportions 
of women in underweight exceeded overall average (9.4%) in at least four of six countries, COD (13.1%), COG 
(13.5%), GMB (15.1%), and NGA (11.3%) (See Table S5). Compared to the study average (8.9%), pregnancy was 
consistently higher in COD (12%), GAB (10.1), MOZ (11.1), and NGA (10.5). In terms of comorbidities, three 
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of those countries accounted for nearly 40% of global malaria cases, NGA (25%), COD (12%), and MOZ (4%). 
In addition, COG and GAB are the only countries that exhibit low levels of household ITN ownership (< 25%) 
according to  WHO44. For HIV, MOZ had one of the highest HIV prevalence (12.4%) in Eastern  Africa36. Finally, 
genetic predisposition related to the sickle haemoglobin (HbS) allele in Central and Western  Africa45 could 
explain COG (Pointe Noire) and GAB (Libreville & Port-gentil) risk outliers.
Limitations
Our study had several limitations worth noting. Most of the factors included in our analysis were self-reported 
variables, which may lead to information bias and generate inaccuracies related to recall and possible reticence 
of participants in disclosing some essential information. Selection bias may be present in the sample since only 
selected individuals who were willing to participate in the survey and met the inclusion criteria were included 
in the analysis. Selection bias might have led to spurious associations and mapping errors for anemia in some 
countries. Another limitation is that we used the latest DHS survey conducted in each country. Therefore, some 
temporal differences among surveys may result in anemia estimates varying significantly over the ten years 
difference among all countries included. Since we restricted the study to the use of each specific DHS territory 
definition, geographies with subsequent subnational variation, and territories with no difference between cities 
and provinces might appear. Lastly, although our individual-based approach identified interactions between 
comorbidities and anemia, the omission of multilevel analysis might lead to ecological fallacy. We suggest future 
research focuses on including interactions between individual and ecological-level factors to better understand 
population-level determinants. Finally, because this is an individual analysis based on cross-sectional surveys, 
our study was limited in deriving conclusions about the direction of causality. Hence, our results should be 
interpreted with caution.
Conclusions
Using data from 27 countries and including more than 198,000 participants, this study examined potential 
determinants and the geospatial structure of anemia in women of reproductive age across SSA. Several inter-
ventions could be derived from this study. For poverty-related determinants, policymakers’ efforts should focus 
on scaling up anemia screening and parasitic infections treatments to identify and reduce the likelihood of an 
anemia diagnosis in high-risk communities, especially women. Also, additional efforts from local governments 
are required to ensure that vulnerable high-risk subpopulations are not left behind within the health-related 
SDGs (2nd Zero hunger, 6th Clean water and sanitation). For co-occurrent epidemics and their spatial distri-
bution in Africa, our study results highlight the additional challenges that comorbidities can pose to women 
at risk of anemia in SSA. We suggest multi-disease interventions in locations characterized by high comorbid-
ity scenarios to improve health outcomes. Knowledge about the contribution of known major drivers and the 
spatial distribution of anemia risk can mitigate operational constraints and help to the design of geographically 
targeted programs in SSA. Future research needs to focus on understanding the causes and consequences of 
other important geographical disparities such as comparisons between urban and rural areas for all population 
groups at different scales.
Data availability
Data are available in a public, open-access repository. The data that support the findings of this study are avail-
able from the Demographic and Health Surveys (http:// www. measu redhs. com). We sought and were granted 
permission to use the core data set for this analysis by Measure DHS.
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